{
    "code": 0,
    "data": [
        {
            "co_code": 89433,
            "bse_code": 544292,
            "isin": "INE013P01021",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Under Regulation 30 Read With Schedule III Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015",
            "news_body": "Intimation of ESG Rating by SES ESG Research Private Limited",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ed2af889-5e43-4ca6-8ee8-3e8b2f84876b.pdf",
            "news_date": "2026-02-12 16:37:44"
        },
        {
            "co_code": 89433,
            "bse_code": 544292,
            "isin": "INE013P01021",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "OneSource-Hikma partnership secures approval to commercialise generic version of Ozempic in Saudi Arabia",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c574773a-6f4f-4bf3-8fa4-7550bc49ee65.pdf",
            "news_date": "2026-02-11 08:21:27"
        },
        {
            "co_code": 89433,
            "bse_code": 544292,
            "isin": "INE013P01021",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Onesource Specialty Pharma Limited Has Informed The Exchange Regarding Disclosure Under Regulation 29(2) Of The SEBI (Substantial Acquisition Of Shares & Takeovers)Regulations 2011 And Regulation 7(2) Of SEBI (Prohibition Of Insider Trading) Regulations 2",
            "news_body": "OneSource Specialty Pharma Limited has informed the Exchange regarding purchase of 443906 equity shares of the Company by the Promoter group entities between January 30 2026 and February 04 2026.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8893265d-6968-43b5-a8c7-8da7be955811.pdf",
            "news_date": "2026-02-04 19:40:57"
        },
        {
            "co_code": 89433,
            "bse_code": 544292,
            "isin": "INE013P01021",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "news_body": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Tenshi Pharmaceuticals Pvt Ltd & PACs",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7C331B5F_29D1_4A9A_86E4_A500272CDFD5_175541.pdf",
            "news_date": "2026-02-04 17:55:47"
        },
        {
            "co_code": 89433,
            "bse_code": 544292,
            "isin": "INE013P01021",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "news_body": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Tenshi Pharmaceuticals Pvt Ltd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6EE80CC0_C801_4A48_952D_5BCFE9293E65_174519.pdf",
            "news_date": "2026-02-04 17:45:23"
        },
        {
            "co_code": 89433,
            "bse_code": 544292,
            "isin": "INE013P01021",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "news_body": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Pronomz Ventures LLP & PACs",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=B2FD8781_F31C_4DFB_BCD8_1F9F0BA3333F_174355.pdf",
            "news_date": "2026-02-04 17:43:58"
        },
        {
            "co_code": 89433,
            "bse_code": 544292,
            "isin": "INE013P01021",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "news_body": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Pronomz Ventures LLP",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=93AA6268_BE5B_410E_AF0D_DE6200EC7DE0_101953.pdf",
            "news_date": "2026-02-03 10:19:58"
        },
        {
            "co_code": 89433,
            "bse_code": 544292,
            "isin": "INE013P01021",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "news_body": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Tenshi Pharmaceuticals Pvt Ltd & PACs",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=57953DB0_CB65_4F32_A28F_B7AF6CF5A7F8_101715.pdf",
            "news_date": "2026-02-03 10:17:28"
        },
        {
            "co_code": 89433,
            "bse_code": 544292,
            "isin": "INE013P01021",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Transcript of Earnings Call pertaining to unaudited Financial Results of the Company for the quarter ended December 31 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f9a54424-cf34-41e2-8590-eba15ca29830.pdf",
            "news_date": "2026-01-30 21:42:55"
        },
        {
            "co_code": 89433,
            "bse_code": 544292,
            "isin": "INE013P01021",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Disclosure Under Regulation 29(2) Of SEBI (SAST) Regulations 2011 And Regulation 7(2) Of SEBI (PIT) Regulations 2015",
            "news_body": "Disclosure under Regulation 29(2) of SEBI (SAST) Regulations 2011 and Regulation 7(2) of SEBI (PIT) Regulations 2015. \r\nPromoter entity (Tenshi Pharmaceuticals Private Limited) has purchased 200000 equity shares of the Company from the market on January 282026.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8b795e80-ebe3-4dc0-b2ec-1f2fffa3d6aa.pdf",
            "news_date": "2026-01-28 18:54:10"
        },
        {
            "co_code": 89433,
            "bse_code": 544292,
            "isin": "INE013P01021",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "news_body": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Tenshi Pharmaceuticals Pvt Ltd & PACs",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4ACB2EC7_61F6_40D1_BD66_C404599785A1_170159.pdf",
            "news_date": "2026-01-28 17:02:03"
        },
        {
            "co_code": 89433,
            "bse_code": 544292,
            "isin": "INE013P01021",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper advertisement- Unaudited financial results of the Company for the quarter ended December 31 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=690ac556-7de8-4f34-a338-279dd9e0651d.pdf",
            "news_date": "2026-01-25 14:44:56"
        },
        {
            "co_code": 89433,
            "bse_code": 544292,
            "isin": "INE013P01021",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release (Revised)",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release (Revised)",
            "news_body": "In the previous intimation made (i.e. only in the subject line while submitting to the exchange)the date of the original press release submission was mentioned as January 23 2025 instead of January 23 2026",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1c0c82cc-1048-40f9-a1a7-c4a8cc52e14a.pdf",
            "news_date": "2026-01-24 14:15:36"
        },
        {
            "sym": "ONESOURCE",
            "disp": "Onesource Specialty Pharma",
            "bse_code": 544292,
            "isin": "INE013P01021",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Earnings Call pertaining to the Unaudited Financial Results for the quarter ended December 31 2025",
            "news_id": "1a2c5dab-4763-4d0f-8fea-2ec5efdb6b7a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e2ed4954-f9f4-4e9a-88db-abf5f5743f40.pdf",
            "news_date": "2026-01-24 14:04:27",
            "seo": "onesource-specialty-pharma-ltd",
            "ltp": 1191.6,
            "ch": -1.6000000000001364,
            "pch": -0.13409319477037684,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 29224,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 89433,
            "bse_code": 544292,
            "isin": "INE013P01021",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Earnings Call pertaining to the Unaudited Financial Results for the quarter ended December 31 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e2ed4954-f9f4-4e9a-88db-abf5f5743f40.pdf",
            "news_date": "2026-01-24 14:04:27"
        },
        {
            "co_code": 89433,
            "bse_code": 544292,
            "isin": "INE013P01021",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release (Revised)",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release (Revised)",
            "news_body": "Addendum to press release (original press release dated January 23 2025).",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6a57cd7e-d114-4da0-9334-65d555489ab7.pdf",
            "news_date": "2026-01-24 13:00:09"
        },
        {
            "co_code": 89433,
            "bse_code": 544292,
            "isin": "INE013P01021",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation of the Earings Presentation (along with Press Release) for the Q3 of FY 2025-26.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dc707f76-4ffa-419e-bb2a-2d33e8875ccf.pdf",
            "news_date": "2026-01-23 21:13:31"
        },
        {
            "co_code": 89433,
            "bse_code": 544292,
            "isin": "INE013P01021",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Approval Of Unaudited Standalone And Consolidated Financial Results For The Quarter Ended December 31 2025",
            "news_body": "Outcome of the Board meeting approving the unaudited financial results for the quarter ended December 31 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c7736926-5799-4488-ad3c-bfe37febf38f.pdf",
            "news_date": "2026-01-23 20:45:42"
        },
        {
            "co_code": 89433,
            "bse_code": 544292,
            "isin": "INE013P01021",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Allotment Of Equity Shares Under The Onesource Specialty Pharma Limited - Employee Stock Option Plan - 2021",
            "news_body": "Intimation of Allotment of Equity shares under OneSource Specialty Pharma Limited  - Employee Stock Option Plan 2021.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c3859feb-51cf-4bf8-ae9d-ad7a7d508cd7.pdf",
            "news_date": "2026-01-21 18:06:59"
        },
        {
            "co_code": 89433,
            "bse_code": 544292,
            "isin": "INE013P01021",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Investor earning call to discuss unaudited financial results of the Company for the quarter ended December 31 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d8168f39-7462-47d0-8744-3d987839eaf2.pdf",
            "news_date": "2026-01-19 15:12:09"
        },
        {
            "co_code": 89433,
            "bse_code": 544292,
            "isin": "INE013P01021",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Intimation Of The Board Meeting Under Regulation 29 Of The SEBI (Listing Obligations And Disclosures Requirements) Regulations 2015 For Approval Of Unaudited Financial Results Of The Company For The Quarter Ended December 31 2",
            "news_body": "Onesource Specialty Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/01/2026 inter alia to consider and approve Approval of unaudited financial results of the Company for the quarter ended December 31 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e7dd6212-9e98-4bb8-af0b-cc778fb6afeb.pdf",
            "news_date": "2026-01-19 14:45:54"
        },
        {
            "co_code": 89433,
            "bse_code": 544292,
            "isin": "INE013P01021",
            "ann_type": "General_Announcements",
            "descriptor": "Amalgamation / Merger / Demerger",
            "caption": "Corporate Action-Amalgamation/ Merger / Demerger",
            "news_body": "Amalgamation of Stelis Pte Limited with OneSource Specialty Pte Limited wholly owned subsidiaries of OneSource Specialty Pharma Limited",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6fcef8a0-827f-4af0-82f4-148d821b26e1.pdf",
            "news_date": "2026-01-14 16:37:57"
        },
        {
            "co_code": 89433,
            "bse_code": 544292,
            "isin": "INE013P01021",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011",
            "caption": "Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011",
            "news_body": "The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Catalyst Trusteeship Ltd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=DC515638_4D23_430D_83D7_B0241AEE81EA_110245.pdf",
            "news_date": "2026-01-09 11:02:52"
        },
        {
            "co_code": 89433,
            "bse_code": 544292,
            "isin": "INE013P01021",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Of The Press Release Of Credit Rating Under Regulation 30 Read With Schedule III Of The SEBI (Listing Obligations And Disclosures Requirements) Regulations 2015",
            "news_body": "Intimation of the press release of credit rating under Regulation 30 read with Schedule III of the SEBI (Listing obligations and Disclosures Requirements) Regulations 2015",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a964c13d-8f0c-4d55-9c09-82b6c037ef31.pdf",
            "news_date": "2025-12-31 19:15:51"
        },
        {
            "co_code": 89433,
            "bse_code": 544292,
            "isin": "INE013P01021",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Intimation of closure of trading window for the declaration of financial results for the quarter ended December 31 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=92a0185d-8993-4e37-a885-5496513d749b.pdf",
            "news_date": "2025-12-24 12:53:10"
        },
        {
            "co_code": 89433,
            "bse_code": 544292,
            "isin": "INE013P01021",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011",
            "caption": "Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.",
            "news_body": "The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on December 23 2025 for Tenshi Pharmaceuticals Pvt Ltd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=40F38FDE_98AF_4283_97E3_C02A09BFF4DC_110911.pdf",
            "news_date": "2025-12-23 11:09:19"
        },
        {
            "co_code": 89433,
            "bse_code": 544292,
            "isin": "INE013P01021",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011",
            "caption": "Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.",
            "news_body": "The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on December 19 2025 for Tenshi Pharmaceuticals Pvt Ltd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=C555B482_E00D_4006_B3BB_1C77056AC9FB_104426.pdf",
            "news_date": "2025-12-19 10:44:31"
        },
        {
            "co_code": 89433,
            "bse_code": 544292,
            "isin": "INE013P01021",
            "ann_type": "General_Announcements",
            "descriptor": "Allotment of ESOP / ESPS",
            "caption": "Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS",
            "news_body": "This intimation is in reference to our intimation dated 09.12.2025 where the number of shares allotted was intimated as 114562136 instead of 23000 equity shares of Re. 1/- each under ONESOURCE ESOP 2021.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=11f75ab6-76cf-4b53-9c90-6a2c9eba550d.pdf",
            "news_date": "2025-12-11 10:26:38"
        },
        {
            "co_code": 89433,
            "bse_code": 544292,
            "isin": "INE013P01021",
            "ann_type": "General_Announcements",
            "descriptor": "Allotment of ESOP / ESPS",
            "caption": "Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS",
            "news_body": "Allotment of 114562136 Equity Shares of RE.1/- each under Onesource ESOP 2021",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=34f50d88-927a-43c4-92ad-7c5551c7933d.pdf",
            "news_date": "2025-12-09 15:38:32"
        },
        {
            "sym": "ONESOURCE",
            "disp": "Onesource Specialty Pharma",
            "bse_code": 544292,
            "isin": "INE013P01021",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of the earnings call for the quarter and half year ended September 30 2025 held on November 12 2025 i.e. after the Board Meeting held on November 11 2025.",
            "news_id": "b16477de-8759-45c8-8cd4-daf9f6f2fd93",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5058b94e-ec42-4d8f-aef1-d5dea9775add.pdf",
            "news_date": "2025-11-18 14:46:12",
            "seo": "onesource-specialty-pharma-ltd",
            "ltp": 1191.6,
            "ch": -1.6000000000001364,
            "pch": -0.13409319477037684,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 29224,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 89433,
            "bse_code": 544292,
            "isin": "INE013P01021",
            "ann_type": "General_Announcements",
            "descriptor": "Earnings Call Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of the earnings call for the quarter and half year ended September 30 2025 held on November 12 2025 i.e. after the Board Meeting held on November 11 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5058b94e-ec42-4d8f-aef1-d5dea9775add.pdf",
            "news_date": "2025-11-18 14:46:12"
        },
        {
            "co_code": 89433,
            "bse_code": 544292,
            "isin": "INE013P01021",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Update On Non-Participation Of The Representatives Of The Company In The Jefferies Conference",
            "news_body": "This in reference to our intimation dated November 13 2025 wherein we had given intimation of participation by the representatives of OneSource Specialty Pharma Limited in Jefferies Global Healthcare Conference scheduled to be held from November 18 2025 upto November 20 2025 in London.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f0cc1e03-97a5-41dc-8562-eae654e96e21.pdf",
            "news_date": "2025-11-18 11:42:58"
        },
        {
            "co_code": 89433,
            "bse_code": 544292,
            "isin": "INE013P01021",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "General Updates",
            "news_body": "The Company is informing the exchange about participation in Jefferies Global Healthcare Conference.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=96b946be-c5e5-4151-9178-7bb2aaab9adc.pdf",
            "news_date": "2025-11-13 19:38:32"
        },
        {
            "sym": "ONESOURCE",
            "disp": "Onesource Specialty Pharma",
            "bse_code": 544292,
            "isin": "INE013P01021",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Earnings Call held on November 12 2025 at 15:00 Hrs (IST) for discussing unaudited financial results of the Company for the quarter and half year ended September 30 2025.",
            "news_id": "850ce1a1-2fc4-475f-ab04-19c02d591486",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=70ed8ddf-b81e-4766-b263-da1dcba39ec2.pdf",
            "news_date": "2025-11-13 13:25:18",
            "seo": "onesource-specialty-pharma-ltd",
            "ltp": 1191.6,
            "ch": -1.6000000000001364,
            "pch": -0.13409319477037684,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 29224,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 89433,
            "bse_code": 544292,
            "isin": "INE013P01021",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Earnings Call held on November 12 2025 at 15:00 Hrs (IST) for discussing unaudited financial results of the Company for the quarter and half year ended September 30 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=70ed8ddf-b81e-4766-b263-da1dcba39ec2.pdf",
            "news_date": "2025-11-13 13:25:18"
        },
        {
            "co_code": 89433,
            "bse_code": 544292,
            "isin": "INE013P01021",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper Advertisement published on November 13 2025 for the financial results for quarter and half year ended September 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=41fa0527-4c0b-4c82-a6d4-10f717cc826b.pdf",
            "news_date": "2025-11-13 13:16:56"
        },
        {
            "co_code": 89433,
            "bse_code": 544292,
            "isin": "INE013P01021",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Investor Presentation",
            "news_body": "Investor presentation of the financial results for the quarter ended September 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=14e30e87-875e-4221-a841-51cbdcec660a.pdf",
            "news_date": "2025-11-12 07:38:18"
        },
        {
            "co_code": 89433,
            "bse_code": 544292,
            "isin": "INE013P01021",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Press Release for the financial results for the quarter ended September 302025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1b6228be-54fd-44fc-bf96-f48bfc567654.pdf",
            "news_date": "2025-11-11 22:14:06"
        },
        {
            "sym": "ONESOURCE",
            "disp": "Onesource Specialty Pharma",
            "bse_code": 544292,
            "isin": "INE013P01021",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": " Financial Results For The Quarter And Half Year Ended September 30 2025.",
            "news_body": "Financial Results for the quarter and half year ended September 30 2025",
            "news_id": "95a41411-a10f-43b7-acbc-39e561074d0d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=db6745d9-c20a-4764-ac80-0f621cec4646.pdf",
            "news_date": "2025-11-11 17:56:05",
            "seo": "onesource-specialty-pharma-ltd",
            "ltp": 1191.6,
            "ch": -1.6000000000001364,
            "pch": -0.13409319477037684,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 29224,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 89433,
            "bse_code": 544292,
            "isin": "INE013P01021",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": " Financial Results For The Quarter And Half Year Ended September 30 2025.",
            "news_body": "Financial Results for the quarter and half year ended September 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=db6745d9-c20a-4764-ac80-0f621cec4646.pdf",
            "news_date": "2025-11-11 17:56:05"
        },
        {
            "co_code": 89433,
            "bse_code": 544292,
            "isin": "INE013P01021",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of The Board Meeting Held On 11/11/2025 To Approve The Financial Results For The Quarter And Half Year Ended September 30 2025.",
            "news_body": "Outcome of the Board Meeting held on 11/11/2025 to approve the financial results for the quarter and half year ended September 30 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1dc9636b-5c0e-4cb9-b7f2-5861d0bcf540.pdf",
            "news_date": "2025-11-11 17:49:09"
        },
        {
            "co_code": 89433,
            "bse_code": 544292,
            "isin": "INE013P01021",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Revised timing of earnings call earlier intimated on November 05 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=872c6a07-ed6d-4ee6-a818-7a1d0c94237b.pdf",
            "news_date": "2025-11-07 20:07:02"
        },
        {
            "co_code": 89433,
            "bse_code": 544292,
            "isin": "INE013P01021",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Prior Intimation on Earnings call scheduled on 12th November 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5f8802d9-fb17-46bc-8ed6-e07a948df402.pdf",
            "news_date": "2025-11-05 18:04:13"
        },
        {
            "co_code": 89433,
            "bse_code": 544292,
            "isin": "INE013P01021",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Approving The Financial Results For The Quarter And Half Year Ended September 30 2025.",
            "news_body": "Onesource Specialty Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2025 inter alia to consider and approve the financial results for the quarter and half year ended September 30 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cbb965e6-cb57-4eb5-b6ab-da9ebc9e4fe3.pdf",
            "news_date": "2025-11-05 17:50:08"
        },
        {
            "co_code": 89433,
            "bse_code": 544292,
            "isin": "INE013P01021",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Investor Presentation",
            "news_body": "Investor Presentation",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=33806495-00c9-46a9-94af-ba64887fbac6.pdf",
            "news_date": "2025-09-26 23:19:56"
        },
        {
            "co_code": 89433,
            "bse_code": 544292,
            "isin": "INE013P01021",
            "ann_type": "General_Announcements",
            "descriptor": "Scheme of Arrangement",
            "caption": "Announcement under Regulation 30 (LODR)-Scheme of Arrangement",
            "news_body": "Intimation of Composite Scheme of Arrangement",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=925c9a6a-8233-4216-90a1-f99be21980b3.pdf",
            "news_date": "2025-09-26 22:56:26"
        },
        {
            "co_code": 89433,
            "bse_code": 544292,
            "isin": "INE013P01021",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Intimation of Closure of Trading Window for the Quarter ended September 30 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=33377c92-af3a-4095-987d-37954f7222f7.pdf",
            "news_date": "2025-09-26 18:15:35"
        },
        {
            "co_code": 89433,
            "bse_code": 544292,
            "isin": "INE013P01021",
            "ann_type": "General_Announcements",
            "descriptor": "AGM",
            "caption": "Voting Results Of The Annual General Meeting Held On 22Nd September 2025",
            "news_body": "Voting Results of the Annual General Meeting held on 22nd September 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=351d7b42-c36e-45e2-8a11-9a9631641565.pdf",
            "news_date": "2025-09-24 16:31:58"
        },
        {
            "co_code": 89433,
            "bse_code": 544292,
            "isin": "INE013P01021",
            "ann_type": "Outcome",
            "descriptor": "AGM",
            "caption": "Shareholder Meeting / Postal Ballot-Outcome of AGM",
            "news_body": "Proceedings of 18th AGM held on September 22 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b1c73af6-2859-4749-afaa-5e444fc4790b.pdf",
            "news_date": "2025-09-22 22:26:53"
        },
        {
            "co_code": 89433,
            "bse_code": 544292,
            "isin": "INE013P01021",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "The Company has scheduled an Analyst/ Institutional investor meet on September 29 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fe7a866c-92c6-4379-b048-5dee0e8d5485.pdf",
            "news_date": "2025-09-22 19:29:20"
        },
        {
            "co_code": 89433,
            "bse_code": 544292,
            "isin": "INE013P01021",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "The Company has scheduled an Institutional Investor/ Analyst meet on September 25 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e83214d9-a6f4-4e77-a8be-d01ee6e97355.pdf",
            "news_date": "2025-09-22 19:06:34"
        },
        {
            "co_code": 89433,
            "bse_code": 544292,
            "isin": "INE013P01021",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "The Company is scheduled to participate in Group investor meeting on September 05 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=69ceea03-ea8a-476d-921f-4b5dea83ebb4.pdf",
            "news_date": "2025-09-02 18:55:26"
        },
        {
            "co_code": 89433,
            "bse_code": 544292,
            "isin": "INE013P01021",
            "ann_type": "General_Announcements",
            "descriptor": "AGM",
            "caption": "Newspaper Advertisement",
            "news_body": "Newspaper Advertisement for Notice of 18th Annual General Meeting",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=32d3bcd9-16d9-4751-86b2-f57f965e0ef2.pdf",
            "news_date": "2025-08-30 15:44:39"
        },
        {
            "co_code": 89433,
            "bse_code": 544292,
            "isin": "INE013P01021",
            "ann_type": "General_Announcements",
            "descriptor": "Business Responsibility and Sustainability Reporting (BRSR)",
            "caption": "Business Responsibility and Sustainability Reporting (BRSR)",
            "news_body": "BRSR",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fe8bd206-b566-42e6-bc1a-e66f5fe78d41.pdf",
            "news_date": "2025-08-29 18:30:13"
        },
        {
            "co_code": 89433,
            "bse_code": 544292,
            "isin": "INE013P01021",
            "ann_type": "Intimation",
            "descriptor": "AGM",
            "caption": "Notice Of The 18Th Annual General Meeting (\"AGM\") (1St AGM Post Listing) Of The Company Is Scheduled To Be Held On Monday September 22 2025 At 17:00 Hrs IST Through Video Conferencing / Other Audio-Visual Means.",
            "news_body": "Notice of the 18th AGM (1st AGM post listing) of the Company is scheduled to be held on September 22 2025 at 17:00 hrs (IST)",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6437d111-42da-4c76-8aa2-9c61edfcc068.pdf",
            "news_date": "2025-08-29 18:26:37"
        },
        {
            "co_code": 89433,
            "bse_code": 544292,
            "isin": "INE013P01021",
            "ann_type": "General_Announcements",
            "descriptor": "Reg. 34 (1) Annual Report",
            "caption": "Reg. 34 (1) Annual Report.",
            "news_body": "Annual Report of the Company for the FY 2024-25",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bc7ae255-5594-44e0-acf6-1b6c228a3a31.pdf",
            "news_date": "2025-08-29 18:20:06"
        },
        {
            "co_code": 89433,
            "bse_code": 544292,
            "isin": "INE013P01021",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "This is to inform the exchange that pursuant of Regulation 30 of SEBI(LODR) Regulations 2015 the representatives of the Company will be participating in the Investor Meet scheduled by Motilal Oswal 21st Annual Global Investor Conference 2025 .",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4e984226-fd88-452b-9958-19b541be0bcc.pdf",
            "news_date": "2025-08-26 15:55:35"
        },
        {
            "sym": "ONESOURCE",
            "disp": "Onesource Specialty Pharma",
            "bse_code": 544292,
            "isin": "INE013P01021",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of the Earnings call held on August 05 2025",
            "news_id": "95c12847-49f7-4b6c-81c8-6b99385e67e4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=48bc2dff-06ad-4fe0-ab4e-f965913c4674.pdf",
            "news_date": "2025-08-12 11:25:26",
            "seo": "onesource-specialty-pharma-ltd",
            "ltp": 1191.6,
            "ch": -1.6000000000001364,
            "pch": -0.13409319477037684,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 29224,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 89433,
            "bse_code": 544292,
            "isin": "INE013P01021",
            "ann_type": "General_Announcements",
            "descriptor": "Earnings Call Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of the Earnings call held on August 05 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=48bc2dff-06ad-4fe0-ab4e-f965913c4674.pdf",
            "news_date": "2025-08-12 11:25:26"
        },
        {
            "co_code": 89433,
            "bse_code": 544292,
            "isin": "INE013P01021",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Intimation of Newspaper publication of Financial Results for the Quarter ended June 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8d5df2cb-619c-4fb1-8571-7a614039c850.pdf",
            "news_date": "2025-08-06 15:08:07"
        },
        {
            "co_code": 89433,
            "bse_code": 544292,
            "isin": "INE013P01021",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "General Update",
            "news_body": "General Update",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9b2ee96e-1213-44ab-b2bb-55912ca8dee6.pdf",
            "news_date": "2025-08-05 18:02:49"
        },
        {
            "sym": "ONESOURCE",
            "disp": "Onesource Specialty Pharma",
            "bse_code": 544292,
            "isin": "INE013P01021",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Intimation of the Audio Recording of Earnings call pertaining to the Unaudited Financial Results for the quarter ended June 30 2025",
            "news_id": "c06cda09-0be8-4ccc-8953-8e6cf3069b96",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=90b73cfb-4867-4727-8bcc-bb5e0e78fe50.pdf",
            "news_date": "2025-08-05 13:24:58",
            "seo": "onesource-specialty-pharma-ltd",
            "ltp": 1191.6,
            "ch": -1.6000000000001364,
            "pch": -0.13409319477037684,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 29224,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 89433,
            "bse_code": 544292,
            "isin": "INE013P01021",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Intimation of the Audio Recording of Earnings call pertaining to the Unaudited Financial Results for the quarter ended June 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=90b73cfb-4867-4727-8bcc-bb5e0e78fe50.pdf",
            "news_date": "2025-08-05 13:24:58"
        },
        {
            "co_code": 89433,
            "bse_code": 544292,
            "isin": "INE013P01021",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Press release",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=aae0592d-87dd-4bd0-82ca-b15f46e9bef3.pdf",
            "news_date": "2025-08-04 21:32:51"
        },
        {
            "co_code": 89433,
            "bse_code": 544292,
            "isin": "INE013P01021",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "General Updates",
            "news_body": "In-principle approval by the Board to evaluate acquisition of Sterile Injectable CDMO and CMO businesss of Steriscience Pte. Limited and Brooks Steriscience Limited",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fa8944c8-d949-4544-9aed-3e82f2dc17ef.pdf",
            "news_date": "2025-08-04 21:09:42"
        },
        {
            "co_code": 89433,
            "bse_code": 544292,
            "isin": "INE013P01021",
            "ann_type": "General_Announcements",
            "descriptor": "Allotment of ESOP / ESPS",
            "caption": "Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS",
            "news_body": "The Company has allotted 59195 Equity shares under ONESOURCE ESOP 2021 scheme to the eligible employees upon exercise of vested options.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=63b8efc7-a1a8-4242-8a92-199fe50741c9.pdf",
            "news_date": "2025-08-04 21:02:53"
        },
        {
            "co_code": 89433,
            "bse_code": 544292,
            "isin": "INE013P01021",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for The Board Has Approved Standalone And Consolidated Financial Results For The Quarter Ended June 30 2025",
            "news_body": "The Board has approved unaudited standalone and consolidated financial results for the quarter ended June 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3d52824e-aa88-429e-ae60-4d022388eb84.pdf",
            "news_date": "2025-08-04 20:50:12"
        },
        {
            "co_code": 89433,
            "bse_code": 544292,
            "isin": "INE013P01021",
            "ann_type": "Outcome",
            "descriptor": "Postal Ballot",
            "caption": "Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot",
            "news_body": "Intimation of the Voting results along with the Scrutinizers report for the Postal Ballot process held on July 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e2c1559d-9673-4c1c-96b0-0dfbbd31dd4f.pdf",
            "news_date": "2025-07-31 17:25:37"
        },
        {
            "co_code": 89433,
            "bse_code": 544292,
            "isin": "INE013P01021",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Earnings call with the investors and analysts on\r\nTuesday August 05 2025 at 09:00 hrs IST for Q1FY26 financial results.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=62895401-0a08-46c1-820f-788f5f023307.pdf",
            "news_date": "2025-07-31 10:56:24"
        },
        {
            "co_code": 89433,
            "bse_code": 544292,
            "isin": "INE013P01021",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Approval Of The Standalone And Consolidated Financial Results For The Quarter Ended June 30 2025",
            "news_body": "Onesource Specialty Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/08/2025 inter alia to consider and approve the standalone and consolidated financial results for the quarter ended June 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=741fbb7a-014a-44d9-9420-8de2fc1f4426.pdf",
            "news_date": "2025-07-29 15:23:28"
        },
        {
            "co_code": 89433,
            "bse_code": 544292,
            "isin": "INE013P01021",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "General-Updates",
            "news_body": "General Updates",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=969a89db-d0d3-472f-a8d6-803292d729f1.pdf",
            "news_date": "2025-07-15 17:30:08"
        },
        {
            "co_code": 89433,
            "bse_code": 544292,
            "isin": "INE013P01021",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "Mr. Jeffrey Wong is appointed as the Chief Business Officer of the Company w.e.f July 07 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=09824a66-35f3-4b37-a8b7-136c796c3542.pdf",
            "news_date": "2025-07-07 19:01:02"
        },
        {
            "co_code": 89433,
            "bse_code": 544292,
            "isin": "INE013P01021",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011",
            "caption": "Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.",
            "news_body": "The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on July 07 2025 for Tenshi Pharmaceuticals Pvt Ltd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=50440B20_136F_422B_9D89_C04A7E39905A_164334.pdf",
            "news_date": "2025-07-07 16:43:38"
        },
        {
            "co_code": 89433,
            "bse_code": 544292,
            "isin": "INE013P01021",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011",
            "caption": "Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.",
            "news_body": "The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on July 01 2025 for Tenshi Pharmaceuticals Pvt Ltd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=F307C408_6C60_4DF5_A464_4B9721E7D2EC_161617.pdf",
            "news_date": "2025-07-01 16:16:23"
        },
        {
            "co_code": 89433,
            "bse_code": 544292,
            "isin": "INE013P01021",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper publication - Notice of postal ballot and remote e-voting",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=72d226ef-bc90-4972-8dba-e3c65f4f5b57.pdf",
            "news_date": "2025-07-01 13:13:10"
        },
        {
            "co_code": 89433,
            "bse_code": 544292,
            "isin": "INE013P01021",
            "ann_type": "Intimation",
            "descriptor": "Postal Ballot",
            "caption": "Shareholder Meeting / Postal Ballot-Notice of Postal Ballot",
            "news_body": "Notice of the Postal Ballot",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ed88549d-7742-4699-ba6c-ca7a5397e83a.pdf",
            "news_date": "2025-06-30 19:24:41"
        },
        {
            "co_code": 89433,
            "bse_code": 544292,
            "isin": "INE013P01021",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Intimation of closure of trading window for the quarter ended June 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=769d7ed6-b2a9-439a-aa11-2b745f5f0c40.pdf",
            "news_date": "2025-06-27 15:32:37"
        },
        {
            "co_code": 89433,
            "bse_code": 544292,
            "isin": "INE013P01021",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011",
            "caption": "Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.",
            "news_body": "The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on June 27 2025 for Tenshi Pharmaceuticals Pvt Ltd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8C8FC57B_FFB0_4C53_AB9C_92EC7238F33D_151941.pdf",
            "news_date": "2025-06-27 15:19:45"
        },
        {
            "co_code": 89433,
            "bse_code": 544292,
            "isin": "INE013P01021",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "Appointment of Mr. Colin Michael Bond as the Additional Independent director for a period of 5 years w.e.f June 23 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=57ff2538-2e21-414c-a1d0-9d05ad1952c3.pdf",
            "news_date": "2025-06-23 22:08:26"
        },
        {
            "co_code": 89433,
            "bse_code": 544292,
            "isin": "INE013P01021",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "General-Updates",
            "news_body": "Intimation of delisting of debt securities of the Company",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0ca5d529-643f-4eff-a2e8-11987b250e88.pdf",
            "news_date": "2025-06-21 18:32:51"
        },
        {
            "co_code": 89433,
            "bse_code": 544292,
            "isin": "INE013P01021",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "The representatives of the entity will be participating in the Specialty Chemicals and Healthcare Investors conference 2025scheduled to be held on June 25 2025 in Mumbai.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ffabc0fe-45bc-4c94-8583-fa5f0de44867.pdf",
            "news_date": "2025-06-18 14:25:24"
        },
        {
            "co_code": 89433,
            "bse_code": 544292,
            "isin": "INE013P01021",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "news_body": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Pronomz Ventures LLP & Others",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5B8E81B8_E3A4_4060_BF9E_C1227C407B43_141451.pdf",
            "news_date": "2025-06-16 14:14:53"
        },
        {
            "co_code": 89433,
            "bse_code": 544292,
            "isin": "INE013P01021",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011",
            "caption": "Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011",
            "news_body": "The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Authum Investment & Infrastructure Ltd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9D9BFE1A_99FC_44B2_A009_A44538263A34_125304.pdf",
            "news_date": "2025-06-16 12:53:08"
        },
        {
            "co_code": 89433,
            "bse_code": 544292,
            "isin": "INE013P01021",
            "ann_type": "General_Announcements",
            "descriptor": "Allotment of ESOP / ESPS",
            "caption": "Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS",
            "news_body": "Allotment of 30000 Equity shares under Onesource Specialty Pharma Limited - Employee Stock Option Scheme 2021 to the eligible employees.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0aae5036-e896-4cbe-8bc2-930e888c0dc5.pdf",
            "news_date": "2025-06-13 18:07:30"
        },
        {
            "co_code": 89433,
            "bse_code": 544292,
            "isin": "INE013P01021",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation of Participation of the Company in a Group Investor meeting hosted by Goldman Sachs on June 16 2025 at Bengaluru Karnataka India.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6bb4ec4e-dd50-4b1b-85ee-156b06c90446.pdf",
            "news_date": "2025-06-11 21:48:40"
        },
        {
            "co_code": 89433,
            "bse_code": 544292,
            "isin": "INE013P01021",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Press Release on subscription of equity shares of Xbrane Biopharma AB Sweden",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=721b4a90-8355-4992-a88b-2a124e118f11.pdf",
            "news_date": "2025-06-11 08:31:38"
        },
        {
            "co_code": 89433,
            "bse_code": 544292,
            "isin": "INE013P01021",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Press Release on US-FDA Compliance status on Onesource",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1b723db7-3595-4f9f-a0c0-bd08ff02c4cf.pdf",
            "news_date": "2025-06-10 08:40:05"
        },
        {
            "co_code": 89433,
            "bse_code": 544292,
            "isin": "INE013P01021",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "General-Updates",
            "news_body": "Update on subscription of equity shares by OneSource Specialty Pharma Limited in Xbrane Biopharma AB Sweden",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2b6eaaeb-8123-48fc-a60c-c6e1347774a2.pdf",
            "news_date": "2025-06-10 08:31:27"
        },
        {
            "co_code": 89433,
            "bse_code": 544292,
            "isin": "INE013P01021",
            "ann_type": "General_Announcements",
            "descriptor": "Credit Rating",
            "caption": "Announcement under Regulation 30 (LODR)-Credit Rating",
            "news_body": "Intimation on Credit Rating",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6eecfefc-6b55-4465-bda6-4f32d858ee74.pdf",
            "news_date": "2025-06-04 12:30:53"
        },
        {
            "co_code": 89433,
            "bse_code": 544292,
            "isin": "INE013P01021",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Announcement Under Regulation 30 Of SEBI (LODR) Regulations 2015",
            "news_body": "Announcement with regard to imposition of fine by the stock exchanges",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f13a4fee-029c-4ad0-a624-e716d42f6721.pdf",
            "news_date": "2025-05-30 16:29:50"
        },
        {
            "co_code": 89433,
            "bse_code": 544292,
            "isin": "INE013P01021",
            "ann_type": "Outcome",
            "descriptor": "Postal Ballot",
            "caption": " Shareholder Meeting / Postal Ballot-Scrutinizer\"s Report",
            "news_body": "Intimation of e-voting results and Scrutinizers report for the Postal Ballot process dated 25.05.2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3967d4dd-c86e-49e6-8d44-de282d7cf4c5.pdf",
            "news_date": "2025-05-27 15:47:45"
        },
        {
            "co_code": 89433,
            "bse_code": 544292,
            "isin": "INE013P01021",
            "ann_type": "Outcome",
            "descriptor": "Postal Ballot",
            "caption": " Shareholder Meeting / Postal Ballot-Scrutinizer\"s Report",
            "news_body": "Intimation of e-voting results and Scrutinizers report for the Postal Ballot process dated 25.05.2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=29ba7ff5-da58-4233-b58e-8ecdd499c640.pdf",
            "news_date": "2025-05-27 15:30:21"
        },
        {
            "co_code": 89433,
            "bse_code": 544292,
            "isin": "INE013P01021",
            "ann_type": "Compliance",
            "descriptor": "Reg.24(A)-Annual Secretarial Compliance",
            "caption": "Compliances-Reg.24(A)-Annual Secretarial Compliance",
            "news_body": "Intimation of Annual Secretarial Compliance Report as on 31.03.2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e062728f-d755-4149-821d-51bed03703cc.pdf",
            "news_date": "2025-05-27 15:25:20"
        },
        {
            "sym": "ONESOURCE",
            "disp": "Onesource Specialty Pharma",
            "bse_code": 544292,
            "isin": "INE013P01021",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Earnings call Transcript",
            "news_id": "a45d496a-64bb-4d3d-b328-768ba48f30fc",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3cbbcae2-b576-46b6-8acb-4c43e18b557a.pdf",
            "news_date": "2025-05-12 11:20:58",
            "seo": "onesource-specialty-pharma-ltd",
            "ltp": 1191.6,
            "ch": -1.6000000000001364,
            "pch": -0.13409319477037684,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 29224,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 89433,
            "bse_code": 544292,
            "isin": "INE013P01021",
            "ann_type": "General_Announcements",
            "descriptor": "Earnings Call Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Earnings call Transcript",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3cbbcae2-b576-46b6-8acb-4c43e18b557a.pdf",
            "news_date": "2025-05-12 11:20:58"
        },
        {
            "co_code": 89433,
            "bse_code": 544292,
            "isin": "INE013P01021",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Announcement Under Regulation 30.",
            "news_body": "Intimation of Interaction of OneSource Specialty Pharma Limited with the  Investors in the meeting hosted by JP Morgan scheduled on 16th May 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e429d29c-e6d0-4ceb-b2d4-90a3823fec48.pdf",
            "news_date": "2025-05-09 18:47:18"
        },
        {
            "co_code": 89433,
            "bse_code": 544292,
            "isin": "INE013P01021",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Intimation of newspaper advertisement",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=16892313-b603-42ea-a34d-4f0833ff59cb.pdf",
            "news_date": "2025-05-08 16:53:39"
        },
        {
            "co_code": 89433,
            "bse_code": 544292,
            "isin": "INE013P01021",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Intimation of Newspaper advertisement",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=961b314f-f773-4add-af8e-a5099817d31b.pdf",
            "news_date": "2025-05-07 19:13:58"
        },
        {
            "sym": "ONESOURCE",
            "disp": "Onesource Specialty Pharma",
            "bse_code": 544292,
            "isin": "INE013P01021",
            "descriptor": "General",
            "cat": "Audio",
            "caption": "Intimation Of Investor Meet Held On May 06 2025",
            "news_body": "Intimation of Audio Recording.",
            "news_id": "61bc05fa-4671-469d-a225-9d927c01b5c6",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=35c7296b-09c7-42e3-b3b3-89de247c04c4.pdf",
            "news_date": "2025-05-06 18:33:52",
            "seo": "onesource-specialty-pharma-ltd",
            "ltp": 1191.6,
            "ch": -1.6000000000001364,
            "pch": -0.13409319477037684,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 29224,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 89433,
            "bse_code": 544292,
            "isin": "INE013P01021",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Of Investor Meet Held On May 06 2025",
            "news_body": "Intimation of Audio Recording.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=35c7296b-09c7-42e3-b3b3-89de247c04c4.pdf",
            "news_date": "2025-05-06 18:33:52"
        },
        {
            "co_code": 89433,
            "bse_code": 544292,
            "isin": "INE013P01021",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Intimation of press release",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=910c0513-238f-4d6a-a4f5-23b5f0d6d2d4.pdf",
            "news_date": "2025-05-05 20:28:22"
        },
        {
            "co_code": 89433,
            "bse_code": 544292,
            "isin": "INE013P01021",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting",
            "news_body": "Outcome of the Board meeting held on May 052025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=54628576-fcff-43e3-8df1-b156b509a918.pdf",
            "news_date": "2025-05-05 20:22:37"
        },
        {
            "co_code": 89433,
            "bse_code": 544292,
            "isin": "INE013P01021",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Schedule of intimation of investors call dated May 062025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dbb4c58f-42cf-4fd2-92d6-b265b3f2f0d6.pdf",
            "news_date": "2025-04-29 22:03:33"
        },
        {
            "co_code": 89433,
            "bse_code": 544292,
            "isin": "INE013P01021",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Prior Intimation Of Board Meeting",
            "news_body": "Onesource Specialty Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/05/2025 inter alia to consider and approve Intimation of Board meeting dated 05.05.2025 at 15:45 hrs for approval of audited financial results for the quarter and year ended March 312025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4f081b51-5a2f-4311-95b2-0280c29bdbad.pdf",
            "news_date": "2025-04-29 21:56:08"
        },
        {
            "co_code": 89433,
            "bse_code": 544292,
            "isin": "INE013P01021",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Intimation of newspaper advertisement for dispatch of postal ballot notice.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=df365b2c-617c-4c7f-969d-4f4a45068944.pdf",
            "news_date": "2025-04-26 18:27:36"
        },
        {
            "co_code": 89433,
            "bse_code": 544292,
            "isin": "INE013P01021",
            "ann_type": "Intimation",
            "descriptor": "Postal Ballot",
            "caption": "Shareholder Meeting / Postal Ballot-Notice of Postal Ballot",
            "news_body": "Intimation of Postal ballot Notice and remote e voting dated April 23 2025 commences from  Saturday April 26 2025 and concludes on Sunday May 25 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4ff78b81-f6a0-4450-90de-3ede487359ef.pdf",
            "news_date": "2025-04-25 19:04:32"
        },
        {
            "co_code": 89433,
            "bse_code": 544292,
            "isin": "INE013P01021",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Registered Office Address",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Registered Office Address",
            "news_body": "Shifting of Registered office of the Company within the  local limits of the city in which the registered office of the Company is situated.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ab213f1e-0f7c-4633-8006-72edb129133f.pdf",
            "news_date": "2025-04-23 17:49:37"
        },
        {
            "co_code": 89433,
            "bse_code": 544292,
            "isin": "INE013P01021",
            "ann_type": "Compliance",
            "descriptor": "Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure ",
            "caption": "Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A",
            "news_body": "  <b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Onesource Specialty Pharma Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>U74140KA2007PLC043095</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>209.43</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>A</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>CARE RATINGS LIMITED</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table>  <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: TRISHA ALLADA <br/>  Designation: COMPLIANCE OFFICER AND COMPANY SECRETARY <br/> EmailId: Trisha.A@onesourcecdmo.com</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: Anurag Bhagania <br/> Designation: Chief Financial Officer  <br/> EmailId: Anurag.Bhagania@onesourcecdmo.com</div> </div> <div> <br/> Date: 23/04/2025<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=46e1fac7-538f-4f4c-a68f-61eb13ef49d1.pdf",
            "news_date": "2025-04-23 17:43:27"
        },
        {
            "sym": "ONESOURCE",
            "disp": "Onesource Specialty Pharma",
            "bse_code": 544292,
            "isin": "INE013P01021",
            "descriptor": "General",
            "cat": "Audio",
            "caption": "Intimation Of The Link Of The Audio Recording Of The Investor Call Held On 29Th January 2025.",
            "news_body": "Intimation of the link of the Audio recording as per Regulation 30 read with Part A Para A of Schedule III of the SEBI ( LODR) Regulations 2015.",
            "news_id": "1ca066e8-98b6-4a07-976c-b5a2a943ff40",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=62e5d771-ea16-42f1-a0e9-10f7df9e78e3.pdf",
            "news_date": "2025-01-30 11:22:38",
            "seo": "onesource-specialty-pharma-ltd",
            "ltp": 1191.6,
            "ch": -1.6000000000001364,
            "pch": -0.13409319477037684,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 29224,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ONESOURCE",
            "disp": "Onesource Specialty Pharma",
            "bse_code": 544292,
            "isin": "INE013P01021",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results-Financial Results For The Quarter Ended December 31. 2024",
            "news_body": "Quarterly results for the quarter ended December 31 2024",
            "news_id": "a36fca19-fb67-47ed-84db-16656e3fed99",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dd527444-b149-4fea-bb61-eb53d68beeaa.pdf",
            "news_date": "2025-01-29 07:42:50",
            "seo": "onesource-specialty-pharma-ltd",
            "ltp": 1191.6,
            "ch": -1.6000000000001364,
            "pch": -0.13409319477037684,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 29224,
            "exch": "NSE",
            "seg": "E"
        }
    ]
}